5PSQ-008 CYP2C19 SNP’s influence on clopidogrel response in peripheral artery disease patients

BackgroundClopidogrel is a prodrug, metabolised to its active metabolite especially by the CYP2C19 enzyme. The effect of CYP2C19 polymorphisms on clopidogrel efficacy in coronary disease had been widely researched. The clopidogrel label recommends testing the CYP2C19 loss of function alleles before...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of hospital pharmacy. Science and practice 2019-03, Vol.26 (Suppl 1), p.A205-A205
Hauptverfasser:	Díaz-Villamarín, X, Dávila-Fajardo, CL, Blánquez-Martínez, D, Fernández-Gómez, E, Antúnez-Rodríguez, A, Raquel, ÁS
Format:	Artikel
Sprache:	eng
Schlagworte:	Survival analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!